Disclaimer

Legal Notice

This web site is provided by Genmab A/S, CVR no. 21023884, Kalvebod Brygge 43, 1560 Copenhagen V, Denmark.

Please read this Legal Notice before using this web site. By using this web site you accept the terms and conditions set out in this Legal Notice. If you do not agree to the terms and conditions set out in this Legal Notice do not use this web site.

Copyright
The content of this web site is protected by Danish and foreign copyright laws. You may download material displayed on this web site only for non-commercial and personal use and provided that you respect and keep intact all copyright, trademark and other proprietary notices. You may not copy, reproduce, republish, upload, post, transmit or distribute in any way the contents of this web site including the text, images, audio and video for either public or commercial use or communication, without prior written permission of Genmab A/S.

Trademarks
The company names, trade names, services names and logos are all owned by Genmab A/S, its affiliates, licensees, licensors or collaboration partners. In particular and without limitation, the following trademarks are all owned by Genmab A/S and its subsidiaries: Genmab®; the Y-shaped Genmab logo®; Genmab in combination with the Y-shaped Genmab logo™; the DuoBody logo®; the HexaBody logo™; HuMax®; HuMax-CD20®; UniBody®; DuoBody® and HexaBody®. Arzerra® is a trademark of Novartis AG or its affiliates. DARZALEX® is a trademark of Janssen Biotech, Inc. Nothing contained on the site may be construed as granting, by implication, or otherwise, any license or right to use any of the trademarks displayed on this site without the prior written permission of Genmab A/S. 

No Warranties and Disclaimer
Genmab A/S makes no warranties or representations either expressed or implied about correctness, accuracy, timeliness or completeness of this web site's content and may discontinue distributing the site without prior notice. The information on this site is provided on an "AS IS" basis without any warranties or representations, either express or implied.

The information on this web site is meant as general guidance only in regard to the subject matter covered and does not constitute any advice or recommendation. You are encouraged to seek professional advice in the particular field with respect to the use of any specific aspects of this web site and to confirm the information contained herein with other sources. In particular, the information is not intended as medical advice and therefore, if you have or suspect you may have any health problems, we recommend that you contact your physician.

Data provided on the Genmab A/S share price is for information only and should not be used as the basis for share trading.

This web site may contain links to web sites operated by other parties. The linked sites are not under the control of Genmab A/S, and Genmab A/S is not responsible for the content available on any other Internet sites linked to this web site. Such links do not imply Genmab A/S' endorsement of material on any other site. Genmab A/S provides links to other Internet sites as a convenience to users, and access to any other Internet sites linked to this web site is at your own risk.

Except for the historical information presented herein, matters discussed on this web site are forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements, e.g. unforeseen exchange rate and interest rate fluctuations, delayed or unsuccessful development projects. Genmab is not under an obligation to update statements regarding the future nor to confirm such statements in relation to actual results.

Your use of the web site or any content on the web site is at your own risk. GENMAB A/S SHALL NOT BE LIABLE FOR ANY LOSS WHETHER DIRECT, INDIRECT, INCIDENTAL OR CONSEQUENTIAL, ARISING OUT OF ACCESS TO, USE OF OR RELIANCE UPON ANY OF THE CONTENT ON THIS WEB SITE OR SITES TO WHICH THIS WEB SITE IS LINKED REGARDLESS OF WHETHER SUCH CONTENT HAS BEEN ACCURATE OR COMPLETE AND GENMAB A/S WILL NOT PAY ANY DAMAGES WHETHER FOR LOSS OR INJURY, PUNITIVE OR OTHERWISE BECAUSE OF ANY SUCH ACCESS TO, USE OF OR RELIANCE UPON ANY OF THE CONTENT ON THIS WEB SITE OR SITES TO WHICH THIS WEB SITE IS LINKED. THIS INCLUDES DAMAGES FOR VIRUSES, WORMS, TROJAN HORSES AND OTHER THREATS THAT MAY INFECT YOUR COMPUTER EQUIPMENT.

Privacy Statement

Genmab A/S is committed to protecting your personal data and privacy. Through the web site Genmab A/S obtains certain personally identifiable information provided by you voluntarily.  

The personally identifiable information is the information you provide to Genmab A/S when signing up for Genmab A/S’s News Alert, Genmab A/S’ Event Alert, logging on to Genmab A/S’s Investor Portal or mailing to Genmab A/S regarding general or business inquiries or with web site feedback. This information will typically be your name, address, occupation, phone number, and e-mail address. The personally identifiable information will only be used to provide the services requested by you and to improve our services to you. You may at all times inform us if you do not wish to be contacted by Genmab A/S any longer. Your personal information may be processed by Emperor Design Consultants Limited, VP Investor Services A/S, NASDAQ OMX Nordic Ltd, NASDAQ OMX Corporate Solutions Inc. (located in the USA) and by Genmab A/S’s affiliated companies, however only if you have been notified in advance that such information may be processed by our affiliated companies.

In addition, we collect information about your visit to our website by use of cookies (see the description of our cookie policy in this link: http://www.genmab.com/cookie-policy).

Any questions, comments, suggestions or other communication that you submit to Genmab A/S via our web site will become the property of Genmab A/S and may be used by Genmab A/S in any fashion and for any purpose whatsoever including without limitation disclosure to Genmab A/S’s affiliated companies, collaboration partners and other individuals and entities. Genmab A/S will treat such communications on a non-confidential basis however we will continue to respect your privacy with respect to these communications.

You may at all times contact Genmab A/S with any questions regarding this Legal Notice or enquires as to the personally identifiable information that Genmab A/S has registered regarding you, including without limitation enquires for the correction or removal of such information. You may contact Genmab A/S via e-mail at info@genmab.com or by mail at Genmab A/S, Kalvebod Brygge 43, 1560 Copenhagen V, Denmark.  

Governing Law and Venue

This Legal Notice and the contents of this web site shall be governed by Danish law without regard to its conflict of law rules. Any dispute arising out of or in relation to this Legal Notice shall be decided solely by the Danish courts. Place of venue shall be Copenhagen, Denmark. 

Back to top